29.08.20141376
Does physical activity modify the relationship between obesity and atrial fibrillation (AF) in women?
28.08.20141508
Risk prediction in elderly patients is increasingly relevant due to longer life expectancy.
27.08.20141533
For the TASMIN-SR trial, Richard J. McManus, FRCGP, and colleagues studied 552 patients aged 35 years and older with baseline systolic BP ?130 mm Hg/diastolic BP ?80 mm Hg who had a history of stroke, CHD, diabetes or chronic kidney disease.
26.08.20141621
После венозной тромбоэмболии ((ВТЭ) тромбоза глубоких вен или легочной эмболии) большинство пациентов принимают варфарин или новые пероральные антикоагулянты в течение 6 - 12 месяцев, после окончания терапии у таких пациентов остается риск рецидива ВТЭ.
25.08.20141780
These results call into question the JNC 8 panel recommendation to relaxsystolic BP targets to <150 mm Hg for patients aged 60 and older, according to the researchers.
22.08.20141491
Ischaemic preconditioning has well-established cardiac and vascular protective effects. Short interventions (one week) of daily ischaemic preconditioning episodes improve conduit and microcirculatory function.
22.08.20141704
The FDA has approved the oral anticoagulant drug apixaban for treating deep vein thrombosis and pulmonary embolism and for preventing recurrent episodes of these conditions, according to the two firms selling the drug.